These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16563636)

  • 41. Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer.
    Gondi V; Bradley K; Mehta M; Howard A; Khuntia D; Ritter M; Tomé W
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):187-95. PubMed ID: 17189070
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PET-CT in radiation oncology: the impact on diagnosis, treatment planning, and assessment of treatment response.
    Heron DE; Andrade RS; Beriwal S; Smith RP
    Am J Clin Oncol; 2008 Aug; 31(4):352-62. PubMed ID: 18845994
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives.
    Nestle U; Kremp S; Grosu AL
    Radiother Oncol; 2006 Nov; 81(2):209-25. PubMed ID: 17064802
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of PET-CT fusion in head and neck cancer.
    Rusthoven KE; Koshy M; Paulino AC
    Oncology (Williston Park); 2005 Feb; 19(2):241-6; dicussion 246, 249-50, 253. PubMed ID: 15770891
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of positron emission tomography in the management of head and neck cancer in the molecular therapy era.
    Garcia C; Flamen P
    Curr Opin Oncol; 2008 May; 20(3):275-9. PubMed ID: 18391626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma.
    Hutchings M; Loft A; Hansen M; Berthelsen AK; Specht L
    Eur J Haematol; 2007 Mar; 78(3):206-12. PubMed ID: 17253974
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.
    Katsoulis IE; Wong WL; Mattheou AK; Damani N; Chambers J; Livingstone JI
    Int J Surg; 2007 Dec; 5(6):399-403. PubMed ID: 17631431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FDG PET/CT in oncology: "raising the bar".
    Patel CN; Goldstone AR; Chowdhury FU; Scarsbrook AF
    Clin Radiol; 2010 Jul; 65(7):522-35. PubMed ID: 20541652
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The impact of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) on planning of radiotherapy].
    Dizendorf E; Baumert B; von Schulthess GK; Luetolf UM; Steinert HC
    Ter Arkh; 2001; 73(10):11-4. PubMed ID: 11763507
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Best practices: consensus on performing positron emission tomography-computed tomography for radiation therapy planning and for therapy response assessment.
    Blodgett T
    Semin Ultrasound CT MR; 2010 Dec; 31(6):506-15. PubMed ID: 21147378
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of PET/CT scanning in radiotherapy planning.
    Jarritt PH; Carson KJ; Hounsell AR; Visvikis D
    Br J Radiol; 2006 Sep; 79 Spec No 1():S27-35. PubMed ID: 16980683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Innovations in radiotherapy planning of head and neck cancers: role of PET.
    Troost EG; Schinagl DA; Bussink J; Boerman OC; van der Kogel AJ; Oyen WJ; Kaanders JH
    J Nucl Med; 2010 Jan; 51(1):66-76. PubMed ID: 20009000
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiation oncology and functional imaging.
    Herrmann T
    Nuklearmedizin; 2005; 44 Suppl 1():S38-40. PubMed ID: 16395977
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methods to delineate tumour for radiotherapy by fluorodeoxyglucose positron emission tomography.
    Gardin I
    Cancer Radiother; 2020 Aug; 24(5):418-422. PubMed ID: 32507519
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Application of PET in radiation oncology].
    Hasegawa M; Uto F; Asakawa I; Kajitani C; Katayama E; Okada H; Hontsu S; Tamamoto T
    Gan To Kagaku Ryoho; 2009 Dec; 36(13):2537-41. PubMed ID: 20009453
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of PET/CT on radiation treatment in patients with esophageal cancer: A systematic review.
    Lu J; Sun XD; Yang X; Tang XY; Qin Q; Zhu HC; Cheng HY; Sun XC
    Crit Rev Oncol Hematol; 2016 Nov; 107():128-137. PubMed ID: 27823640
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biological imaging in radiation therapy: role of positron emission tomography.
    Nestle U; Weber W; Hentschel M; Grosu AL
    Phys Med Biol; 2009 Jan; 54(1):R1-25. PubMed ID: 19060363
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Strategies of assessing and quantifying radiation treatment metabolic tumor response using F18 FDG Positron Emission Tomography (PET).
    Fuss M
    Acta Oncol; 2010 Oct; 49(7):948-55. PubMed ID: 20831482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Application of the PET for Radiation Therapy].
    Mitsumoto T; Tohyama N; Koyama K; Kodama T; Kotaka K; Hatano K
    Igaku Butsuri; 2015; 35(1):39-44. PubMed ID: 26753395
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical target volume delineation for radiotherapy of the esophagus].
    Lazarescu I; Thureau S; Nkhali L; Pradier O; Dubray B
    Cancer Radiother; 2013 Oct; 17(5-6):453-60. PubMed ID: 24011793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.